
Zolpidem, sold as Ambien, is a z-drug, meaning a non-benzodiazepine hypnotic, prescribed for the short-term treatment of insomnia. Chemically it is not a benzodiazepine, but in the body it does what a benzodiazepine does, because it works at the same gamma-aminobutyric acid type A (GABA-A) receptor.
The Ashton Manual says as much. Table 1 in the Manual’s first chapter lists zolpidem alongside the benzodiazepines, with a note that they are chemically different but have the same effects and act by the same mechanisms. The table puts 20 mg of zolpidem at roughly the strength of 10 mg of diazepam and gives it a half-life of about two hours.
So, a person who has taken Ambien every night for years has the same problem as a person on a nightly benzodiazepine. The nervous system has adapted to the drug, and the drug has to be withdrawn the same way: slowly, under medical supervision, never all at once.
Usually not. The Ambien label calls it a short-term treatment, and the Manual reports that benzodiazepines are recommended for two to four weeks only, that tolerance to the sleep effect develops within a few weeks, and its Table 1 puts zolpidem in the same class. Unfortunately, prescriptions get refilled for years, often with the assurance that the pill is safe, and the person who took it exactly as directed finds that they cannot sleep without it.
That is physical dependence, a medical condition caused by the medication. Physical dependence is not addiction. There is no seeking and no escalation, only a nervous system that has rebuilt itself around a nightly drug and objects when the drug is removed.
The distinction matters because the treatment must match the condition. Dependence on a prescribed sleeping pill calls for a gradual medical taper planned with a physician, not addiction treatment. Dr. Mark Leeds, an osteopathic physician and deprescribing specialist in Fort Lauderdale, Florida, treats that condition with a taper, not a program.
Ambien leaves the body quickly. Its own label gives a mean elimination half-life of about two and a half hours, so a dose taken at bedtime is mostly gone by morning.
Think of the drug level as a tide. It comes in at bedtime and is gone by breakfast. Some people whose nervous system has adapted to the tide feel anxious or unwell while it is out.
With a nightly hypnotic, the space between doses is the entire day. For people who report symptoms in that space, the Maudsley Deprescribing Guidelines say a switch to a longer-acting benzodiazepine such as diazepam might be more reasonable than reducing zolpidem itself. Stopping abruptly is not the answer in either case.
The United States Food and Drug Administration (FDA) label for Ambien says, in its section on dependence, that sedative-hypnotics have produced withdrawal signs and symptoms after abrupt discontinuation, and that symptoms may occur with rapid dose reduction or discontinuation. For zolpidem it lists fatigue, nausea, flushing, lightheadedness, uncontrolled crying, vomiting, stomach cramps, panic attack, nervousness and abdominal discomfort.
Convulsions appear in the label’s general description of sedative-hypnotic withdrawal. The Ashton Manual’s warning that abrupt or over-rapid withdrawal can bring on convulsions is written for long-term benzodiazepines, and for zolpidem itself the Manual says the drug can be stopped without a slow taper, as with triazolam. Dr. Leeds does not follow that exception after years of nightly use. Seizures after stopping zolpidem are rare, and a person coming off a nightly dose slowly should not expect one.
Still, a seizure is a medical emergency. Anyone who has one, or any other medical emergency, should call 911 or their local emergency services at once. Anyone having thoughts of suicide can call or text 988, the Suicide and Crisis Lifeline, at any hour.
In 2020 the FDA updated the boxed warning on every benzodiazepine to cover abuse, misuse, addiction, physical dependence and withdrawal reactions, noting that dependence can develop within days to weeks even as prescribed, that stopping abruptly or cutting too quickly can cause withdrawal reactions including seizures, and that a gradual taper is the answer. That update covers benzodiazepines, not zolpidem, yet because the two act by the same mechanism Dr. Leeds applies the same caution to Ambien.
Less than many websites claim. The Manual, written by Professor C. Heather Ashton, contains no zolpidem schedule, and its example schedules are all built around diazepam. What it does say, in Table 1 of the first chapter, is that zolpidem has the same effects and acts by the same mechanisms as the benzodiazepines, and Chapter II groups zolpidem with triazolam as a very short-acting drug that Professor Ashton thought could be stopped without substituting a long-acting benzodiazepine, an exception Dr. Leeds does not follow after years of nightly use.
The Manual’s method for the benzodiazepines has three parts, and Dr. Leeds applies it to zolpidem. Reductions are small, up to one tenth of the dose at each step. In Dr. Leeds’ practice, each step is given time to settle before the next, and a step that does not settle within a few weeks is taken back to the prescriber rather than waited out. The pace belongs to the patient, who the Manual says is usually the best judge of it, and whether the whole process takes six months, twelve or eighteen matters little after years on the drug.
The third part is the switch. For most short-acting benzodiazepines, the Manual moves the person to a long-acting one such as diazepam, so that the daily tide becomes a steady level that can be lowered in tiny amounts.
Dr. Leeds weighs that switch, a crossover taper, one patient at a time. Some people do well reducing zolpidem itself in small or liquid doses, with no substitution. Others, especially on higher doses or with hard daytime symptoms, do better after a move to diazepam on the Manual’s principles; his Ashton Manual approach has its own page.
It looks like months, sometimes longer, and it is shaped around the person rather than a calendar. Dr. Leeds begins with a full history: the dose, how long it has been taken, whether the extended-release form (Ambien CR) is involved, and what happened on any earlier attempt to stop.
The reductions get smaller as the dose gets lower. This is the hyperbolic pattern described in the Maudsley Deprescribing Guidelines: the last few milligrams do far more at the receptor than the first few, so equal cuts feel progressively harsher. Because tablets cannot be divided finely enough, he often prescribes a compounded liquid formulation of the same drug, measured in very small amounts with nothing added.
Informed consent runs through the whole plan. Dr. Leeds explains the risks of tapering and of staying on the drug, the alternatives, and how the taper is expected to end, and the patient keeps the right to slow down, pause or decline at any point. He provides medically supervised tapering by telemedicine to patients throughout Florida, in a concierge practice with one physician.
Rebound insomnia is sleep that is worse than it was before the drug, arriving in the first nights after a dose is cut or the drug is stopped. It is the adapted nervous system showing itself, not proof that the person needs Ambien for life.
A hold is the answer. Instead of cutting again, or going back up, the patient stays at the current dose until the rebound settles, which may take days or a few weeks. The Manual’s advice is, as far as possible, to hold rather than go back up, and a hold often carries a patient through a bad stretch. When it does not, a small updose to the last steady dose, agreed with the prescriber, is a legitimate decision in Dr. Leeds’ practice, not a failure.
If a cut proves too fast, the doctor must help by advising a slower step. If a cut proves easy, patient and doctor may agree to go a bit faster, as tolerated. Nobody is told they are failing the plan, because the plan is adjusted to the person.
The plain habits help, because a taper removes a drug that had been standing in for them. A fixed wake time every day, including weekends, does more than a fixed bedtime. A cool, dark, quiet bedroom, daylight and movement earlier in the day, no caffeine after lunch, and no screens in the last hour before bed all give the sleep system something to work with.
What does not help is another sedative. The Manual warns that zolpidem, zopiclone and zaleplon all have the same actions as benzodiazepines, so swapping one sleeping pill for another, or adding a benzodiazepine on the bad nights, moves the dependence rather than treating it. A patient who is tempted to do that should tell Dr. Leeds, because the honest answer is usually a hold, not a second drug.
A planned crossover to diazepam is a different thing. One drug replaces the other on a schedule, under supervision, and the total then comes down.
Sleep does come back, slowly and unevenly, with good nights and bad nights mixed for a while. That unevenness is healing, not a setback.
Dr. Leeds’ practice offers one thing to people who want off Ambien or generic zolpidem: a gradual, medically supervised taper, planned and adjusted with the patient, by telemedicine across Florida. Anyone who has tried before and could not sleep does not have to try alone. Contact the office through the practice’s contact form to ask about a taper.
No. The Ambien label reports withdrawal signs and symptoms after abrupt discontinuation and with rapid dose reduction, and its Medication Guide tells patients to talk with their healthcare provider about slowly stopping it. The Ashton Manual itself places zolpidem, with triazolam, among the very short-acting drugs that it says can be stopped without substituting a long-acting benzodiazepine, but after years of nightly use Dr. Leeds tapers it gradually, the same way he tapers a benzodiazepine. Seizures after stopping zolpidem are rare. Yet, a seizure is a medical emergency, and anyone who has one should call 911 at once.
A person coming off a nightly dose slowly, under supervision, should not expect one. That is what going slowly is for.
Months at the least, and often a year or longer, shaped around the person rather than a calendar. Professor Ashton wrote that after years on the drug it matters little whether the whole process takes six months, twelve or eighteen, and in Dr. Leeds’ practice each step is given time to settle before the next one, never as an open-ended wait, and a step that does not settle within a few weeks is a decision to make with him rather than a reason to stand still indefinitely. The pace belongs to the patient.
No. The Manual moves people on most short-acting benzodiazepines to a long-acting one such as diazepam, and zolpidem can be switched to diazepam on the same principles. Some people do well reducing zolpidem itself in small or liquid doses, with no substitution, while others, especially on higher doses or with hard daytime symptoms, do better after the move to diazepam. Dr. Leeds decides on that crossover taper with each patient.
No. Rebound insomnia is sleep that is worse than it was before the drug, arriving in the first nights after a cut, and it is the adapted nervous system showing itself rather than proof that the person needs Ambien for life. The answer is a hold at the current dose until it settles, which may take days or a few weeks.
When a hold is not enough, a small updose to the last steady dose, agreed with the prescriber, is a legitimate decision in Dr. Leeds’ practice. Nobody is told they are failing the plan, because the plan is adjusted to the person.
A complex sleep behavior is the subject of the boxed warning on the Ambien label, and the answer is to come off of zolpidem rather than keep taking it. In Dr. Leeds’ practice, that means the prescriber moves the patient off of zolpidem and onto diazepam on the Ashton Manual’s principles. So, the dependence is still tapered gradually rather than dropped all at once.
No. The Manual warns that zolpidem, zopiclone and zaleplon have the same actions as benzodiazepines, so adding a benzodiazepine on the bad nights, or swapping one sleeping pill for another, moves the dependence rather than treating it. A patient who is tempted to do that should tell Dr. Leeds, because the answer is usually a hold rather than a second drug.
A planned crossover to diazepam is a different thing, done on a schedule and under supervision, with the total then coming down.
This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.

Mark Leeds, D.O. is an osteopathic physician and deprescribing specialist in Fort Lauderdale, Florida. He helps patients come off benzodiazepines and sleeping pills with a slow, patient-directed taper guided by the Ashton Manual and the Maudsley Deprescribing Guidelines. Physical dependence is not addiction, and a careful taper is measured in months, not days.
Contact the office today to ask about a slow, medically supervised benzodiazepine taper.





